Home » Topics » BioWorld Science

BioWorld Science
RSS

Syndax and AstraZeneca to test durvalumab plus SNDX-6352 in solid tumors

Feb. 2, 2018

Crinetics Pharmaceuticals identifies new somatostatin SST2 receptor agonists

Feb. 2, 2018

Aduro BioTech and Novartis patent STING-agonists

Feb. 2, 2018

Phase II/III Japanese study of safinamide meets primary endpoint

Feb. 2, 2018

Medshine Discovery patents novel S1P1 agonists

Feb. 2, 2018

CANbridge Life Sciences licenses rights to Nerlynx in Greater China

Feb. 2, 2018

Sage Therapeutics presents new GABA(A) receptor modulators

Feb. 2, 2018

AVROBIO completes series B financing to advance gene therapy pipeline for lysosomal storage disorder

Feb. 2, 2018

FDA grants priority review to patisiran NDA in hereditary ATTR amyloidosis

Feb. 2, 2018

Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis

Feb. 2, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...